Overall, the data support the idea that a new strategy in the prevention of PC may be possible, namely a prophylactic therapy using NK-1 receptor antagonists in chronic pancreatitis to prevent PC, because these antagonists exert an anti-inflammatory and an anti-proliferative effect. Here, TACR1 is linked to chronic pancreatitis.